Medication info
Sitadyon Tablet 100/15 mg (Sitagliptin Phosphate Hydrate, Pioglitazone Hydrochloride)

Sitadyon Tablet 100/15 mg (Sitagliptin Phosphate Hydrate, Pioglitazone Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Sitagliptin Phosphate Hydrate›128.5mg / 1 tabletPioglitazone Hydrochloride›16.53mg / 1 tablet
Manufacturer / importer
(Co., Ltd.) Mothers Pharmaceutical
Appearance
Pink oval film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle
Approval status
Active

MFDS item code 202302365 · Approved 2023.08.08 · Insurance code 622805100

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This drug may be administered as 1 tablet once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly. Assessment of renal function is recommended before and periodically during treatment with this drug. - If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or greater No dosage adjustment based on renal function is required. - Do not administer this drug if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.

Ingredients

Manufacturer
(Co., Ltd.) Mothers Pharmaceutical

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication helps improve blood glucose control in patients with type 2 diabetes through the combination of sitagliptin and pioglitazone. It is effectively used as an adjunct to dietary and exercise therapy for blood glucose management. This contributes to a stable improvement in blood glucose levels for diabetes management.

Dosage and Administration

Adult dosage

This drug may be administered as 1 tablet once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly. Assessment of renal function is recommended before and periodically during treatment with this drug. - If the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or greater No dosage adjustment based on renal function is required. - Do not administer this drug if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.

Precautions

This medication may cause serious allergic reactions in some patients, so if symptoms such as rash, swelling, or difficulty breathing occur during treatment, it should be discontinued immediately and a physician consulted. This medication can cause pancreatitis, so if symptoms such as abdominal pain, nausea, vomiting, or loss of appetite arise during use, immediate medical attention is required. One of the components of this medication may affect heart function, therefore, patients with heart failure or a history of heart failure should not take this medicine. Patients at risk of heart failure should carefully monitor for signs such as weight gain, shortness of breath, or leg swelling while taking this medication, and should inform medical personnel if any abnormal symptoms appear. Dose adjustments are necessary for patients with reduced kidney function, and this medication should be avoided in cases of severe kidney impairment. Women who are pregnant or may become pregnant should avoid taking this medication, and premenopausal women should use appropriate contraception while taking it. This medication is contraindicated in patients with a history of bladder cancer or active bladder cancer, and such patients should not take it. Patients should report any signs of liver dysfunction, such as fatigue, loss of appetite, or jaundice to medical personnel immediately, and regular liver function tests are recommended. This medication can cause hypoglycemia, so particular care should be taken for symptoms of hypoglycemia, especially when taken with insulin or sulfonylureas, and blood glucose levels should be checked frequently. This medication can cause weight gain and edema, so periodic monitoring of weight changes is necessary, and if edema worsens, a consultation with a physician is recommended. Additionally, if severe muscle pain or joint pain occurs during treatment, patients should inform their doctor, and if blisters or rashes appear on the skin, immediate medical attention should be sought. This medication may interact with other drugs, so if other medications are being taken, it is essential to inform medical personnel, and do not discontinue or alter medication usage without consulting them.

Side effects

Hypersensitivity reactions, anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, congestive heart failure, symptoms of heart failure, fluid retention, edema, hypoglycemia, upper respiratory tract infections, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, severe joint pain accompanied by disability, vesicular pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevation of liver enzymes, acute renal failure, bladder cancer, dyspepsia, dizziness, increased serum triglycerides, increased low-density lipoprotein, hyperglycemia, weight gain, sinusitis, pharyngitis, urinary tract infection, low back pain, vertigo, abdominal bloating, elevated serum creatine kinase, hypertension, cardiac arrest, pneumonia, diabetic complications, metabolic acidosis, falls, heart failure, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, fatigue, weakness, loss of appetite, dyspnea, itching, chest pain, chest discomfort, tremors, chills, gastrointestinal disease, epigastric discomfort, numbness, muscle rigidity, uncomfortable head, worsening of liver disease, urticaria, eczema, joint pain, knee abnormalities, arm weakness syndrome, proteinuria, elevated serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, fractures, decreased vision, diabetic macular edema, liver failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to keep air out, and it is best to store it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.